Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Jul 2017 for NextCell Pharma.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Anders Essen-Möller: trading record in brief
All filings by Anders Essen-Möller on record concern NextCell Pharma. Altogether 2 filings, all relating to 5 July 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 7 July 2017: a share grant, in NextCell Pharma. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anders Essen-Möller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
- 96,000 shares0FI:csv-162b2ec3655de0f7fe50
- 120,000 shares@ SEK 25.00100.0% of flowFI:csv-0941ab4c69e153e4312e
2 of 2 declarations